Hughes Daniel, Hughes Aron, Powell Arfon, Al Sarireh Bilal
{"title":"Hepatocellular carcinoma’s 100 most influential manuscripts: A bibliometric analysis","authors":"Hughes Daniel, Hughes Aron, Powell Arfon, Al Sarireh Bilal","doi":"10.5348/100083z04dh2019oa","DOIUrl":null,"url":null,"abstract":"Aims: A bibliometric analysis identifies the major publications that influence the clinical management of Hepatocellular Carcinoma (HCC). Within this study, the 100 most cited HCC articles are noted and analysed. Methods: The search terminology “Hepatocellular carcinoma” and “HCC” were used to search through the Thomson Reuters Web of Science database. The inclusion criteria consisted of English language full articles. The subject matter, author and institution details, year of publication and journal were recorded for the 100 most cited HCC articles. Citation rate index was calculated by dividing the number of citations by the number of years since publication. Results: The search through the Thomson Reuters Web of Science database identified 39,518 eligible papers. The median (range) citation number was 909 (4419 to 458). The most cited article (produced by Llovet et al) discussed the role of Sorafenib in advanced HCC (4419 citations). Hepatology published the most articles (n=20, 20,533 citations), however the Lancet had the overall highest citation number of 39219, across 9 Daniel Hughes1, Aron Hughes2, Arfon Powell3, Bilal AlSarireh4 Affiliations: 1Department of General Surgery, Milton Keynes University Hospital, Standing Way, Eaglestone, Milton Keynes, UK; 2School of Medicine, Cardiff University, Cardiff, UK; 3Division of Cancer and Genetics, Cardiff University, University Hospital of Wales, Cardiff, UK; 4Department of Surgery, Morriston Hospital, ABM University Health Board, Swansea, UK. Corresponding Author: Daniel Hughes, Department of General Surgery, Milton Keynes University Hospital, Standing Way, Eaglestone, Milton Keynes, MK6 5LD, UK; Email: hughesdaniel32@yahoo.com Received: 08 November 2018 Accepted: 15 January 2019 Published: 28 February 2019 published articles. The most discussed topic was HCC management (n=31), followed by prognosis (n=18) and aetiology (n=15). Conclusion: This bibliometric analysis has identified the 100 most cited HCC articles. Through integrating new knowledge into clinical practice, this has enabled novel treatment strategies to be utilised for patients with HCC. This study highlights what makes a citable article and may aid in the development for future HCC research themes.","PeriodicalId":40532,"journal":{"name":"International Journal of Hepatobiliary and Pancreatic Diseases","volume":" ","pages":""},"PeriodicalIF":0.3000,"publicationDate":"2019-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"6","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Hepatobiliary and Pancreatic Diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5348/100083z04dh2019oa","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 6
Abstract
Aims: A bibliometric analysis identifies the major publications that influence the clinical management of Hepatocellular Carcinoma (HCC). Within this study, the 100 most cited HCC articles are noted and analysed. Methods: The search terminology “Hepatocellular carcinoma” and “HCC” were used to search through the Thomson Reuters Web of Science database. The inclusion criteria consisted of English language full articles. The subject matter, author and institution details, year of publication and journal were recorded for the 100 most cited HCC articles. Citation rate index was calculated by dividing the number of citations by the number of years since publication. Results: The search through the Thomson Reuters Web of Science database identified 39,518 eligible papers. The median (range) citation number was 909 (4419 to 458). The most cited article (produced by Llovet et al) discussed the role of Sorafenib in advanced HCC (4419 citations). Hepatology published the most articles (n=20, 20,533 citations), however the Lancet had the overall highest citation number of 39219, across 9 Daniel Hughes1, Aron Hughes2, Arfon Powell3, Bilal AlSarireh4 Affiliations: 1Department of General Surgery, Milton Keynes University Hospital, Standing Way, Eaglestone, Milton Keynes, UK; 2School of Medicine, Cardiff University, Cardiff, UK; 3Division of Cancer and Genetics, Cardiff University, University Hospital of Wales, Cardiff, UK; 4Department of Surgery, Morriston Hospital, ABM University Health Board, Swansea, UK. Corresponding Author: Daniel Hughes, Department of General Surgery, Milton Keynes University Hospital, Standing Way, Eaglestone, Milton Keynes, MK6 5LD, UK; Email: hughesdaniel32@yahoo.com Received: 08 November 2018 Accepted: 15 January 2019 Published: 28 February 2019 published articles. The most discussed topic was HCC management (n=31), followed by prognosis (n=18) and aetiology (n=15). Conclusion: This bibliometric analysis has identified the 100 most cited HCC articles. Through integrating new knowledge into clinical practice, this has enabled novel treatment strategies to be utilised for patients with HCC. This study highlights what makes a citable article and may aid in the development for future HCC research themes.